Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Kanfer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|April 26, 2003
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of responseEdward D Seaton, Richard M Szydlo, Edward Kanfer, et al.
In Vivo (Athens, Greece)|November 4, 2020
Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell CancersAnand Sharma, Deshveer S Babra, Priya V Joshi, et al.
Blood|March 16, 2002
Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemiaJyoti Wadhwa, Richard M Szydlo, Jane F Apperley, et al.
Lancet (London, England)|August 29, 2003
Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfaDavid Marin, Sarah Marktel, Richard Szydlo, et al.
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Blood|June 22, 2010
Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myelomaIan H Gabriel, Ruhena Sergeant, Richard Szydlo, et al.
Bone Marrow Transplantation|April 17, 2021
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMTToby A Eyre, Sophie Caillard, Herve Finel, et al.
Clinical Genitourinary Cancer|July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Bone Marrow Transplantation|February 27, 2019
Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working PartyKai Hübel, Alessandro Re, Ariane Boumendil, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|April 26, 2003
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of responseEdward D Seaton, Richard M Szydlo, Edward Kanfer, et al.
In Vivo (Athens, Greece)|November 4, 2020
Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell CancersAnand Sharma, Deshveer S Babra, Priya V Joshi, et al.
Blood|March 16, 2002
Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemiaJyoti Wadhwa, Richard M Szydlo, Jane F Apperley, et al.
Lancet (London, England)|August 29, 2003
Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfaDavid Marin, Sarah Marktel, Richard Szydlo, et al.
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Blood|June 22, 2010
Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myelomaIan H Gabriel, Ruhena Sergeant, Richard Szydlo, et al.
Bone Marrow Transplantation|April 17, 2021
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMTToby A Eyre, Sophie Caillard, Herve Finel, et al.
Clinical Genitourinary Cancer|July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Bone Marrow Transplantation|February 27, 2019
Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working PartyKai Hübel, Alessandro Re, Ariane Boumendil, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Pageof 2